Publication / Source: Bioanalysis 3(10)
Authors: Greef VJ
The recent Montreux Symposium on LC–MS held in 2010 provided an insight into the key areas of present achievements and future developments in LC–MS. This domain is rapidly changing from a technology- to an application-driven enterprise. New demands for advanced options are coming from (medical) biology, biotechnology, pharmaceutical and nutrition research. In particular, new diagnostic options based on -omics technologies, miniaturization and advanced data handling are rapidly being developed in relation to questions coming from personalized medicine, claim support in nutritional research, biotechnology production support and the human microbiome.